Stocks
Li Auto -10.7%: all-time low broken, short in management phase at +12.02%
Li Auto stock falls 10.7% and closes below its all-time low, with the sell signal in its management phase in week 10. Our model flags the November 25 earnings report, which could bring wide swings in either direction.
Leonardo -4.5%: the sell signal's short is now 9.53% in profit
Leonardo stock drops 4.5% and the sell signal, now in week 12, is in its management phase with the short 9.53% in profit. Price broke below its 4-week low but closed back above, in an area that has already halted the decline 4 times.
Kyverna Therapeutics -15.6%: the short trade is up 42.97% in week 24
Kyverna Therapeutics stock falls 15.6%, with the sell signal in week 24 and the trade in its management phase. Our model has the short 42.97% in profit since entry, and the decline has started to carve out lower lows.
Eastman Kodak -3.9%: the sell signal remains in its management phase
Eastman Kodak stock slips 3.9% as the sell signal, now in week 5, remains in its management phase. The short stands 11.75% in profit since entry, and our model sees a decline that has started to carve out lower lows.
Coca-Cola -2.3%: buy signal still running in week 5, scaling-out window next
Coca-Cola stock slips 2.3% on the week, with the buy signal in week 5 and still 3.29% up since entry. Our model indicates a full position size for new entries and places the next scaling-out window, for 10% of the position, in week 6.
Kinder Morgan -4.9%: the early-exit warning on the short still stands
Kinder Morgan stock falls 4.9% in week 2 of the sell signal, with the short 1.34% at a loss. Our model keeps its early-exit warning in place, issued after a confirmation week that closed bullish, and advises against opening a fresh short now.
Klabin -3.5%: sell signal in its management phase, short 6.70% in profit
Trading latinoamerica: Klabin stock falls 3.5% while the week-8 sell signal is in its management phase, short 6.70% in profit. The shares broke their 12-week low and closed below it, a sign of weakness in our model's reading.
Kering -6.7%: price breaks its 52-week low as the short gains 32.21%
Kering stock drops 6.7%, with the sell signal in week 12 and in its management phase, the short now 32.21% in profit. Our model reads the break below the 52-week low, with a close under it, as a sign of weakness.
Johnson & Johnson -5.3%: the buy signal, in week 3, slips to 1% below entry
Johnson & Johnson stock drops 5.3%, leaving the buy signal, now in week 3, 1% below entry. Our model indicates a full position size, and the next scaling-out window, for 10% of the position, comes in week 6.
JPMorgan Chase -10.3%: the 12-week low gives way, short 9.48% in profit
JPMorgan Chase stock drops 10.3%, and the sell signal, now in week 8, is in its management phase with the short 9.48% in profit. Price closed below its 12-week low, which our model reads as a sign of weakness.
JD.com -10.8%: a new sell signal fires, yet shorting is not advised
JD.com stock drops 10.8% this week and triggers a new sell signal on the Nasdaq. Our model still advises against opening a short: historically, short selling on the signal has closed at a loss on average.
IXUS ETF -8.9%: sell signal in week 6, with the short now up 11.21%
IXUS, the international equity ETF, drops 8.9% while its sell signal, now in week 6, is in the management phase. In our model's technical analysis, the short is up 11.21% and the close below the 24-week low points to weakness.
IWV -8.3%: the short on the Russell 3000 ETF clears both model targets
IWV, the Russell 3000 ETF, falls 8.3% while the sell signal, now in week 2, has the short 6.02% in profit. In our technical analysis both model targets have been passed, and the model rates opening a new short as high risk.
IWB -8.3%: sell signal in week 2, with the first target already passed
IWB, the iShares Russell 1000 ETF, falls 8.3% as the sell signal, now in week 2, puts the short 6.03% in profit. In our technical analysis, the model's first target has already been passed, while opening a new short now carries high risk.